Direct role of p53 on homologous recombination;Rôle direct de p53 dans la recombinaison homologue

Medecine/Sciences

Volumn 21, Issue 1, 2005, Pages 43-48

  Saintigny, Yannick ^a   Bertrand, Pascale ^a   Lopez, Bernard S ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL PROLIFERATION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOME; HUMAN; NONHUMAN; PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 12344310588     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200521143     Document Type: Review

References (39)

1. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
2. Amor M, Parker KL, Globerman H, et al. Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1988; 85: 1600-4.
3. Purandare SM, Patel PI. Recombination hot spots and human disease. Genome Res 1997; 7: 773-86.
4. Wiesmuller L, Cammenga J, Deppert WW. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J Virol 1996; 70: 737-44.
5. Bishop AJ, Hollander MC, Kosaras B, et al. Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development. Cancer Res 2003; 63: 5335-43.
6. Meyn MS, Strasfeld L, Allen C. Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol 1994; 66: S141-9.
7. Bertrand P, Rouillard D, Boulet A, et al. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 1997; 14: 1117-22.
8. Mekeel KL, Tang W, Kachnic LA, et al. Inactivation of p53 results in high rates of homologous recombination. Oncogene 1997; 14: 1847-57.
9. Gebow D, Miselis N, Liber HL. Homologous and nonhomologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation. Mol Cell Biol 2000; 20: 4028-35.
10. Lu X, Lozano G, Donehower LA. Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system. Mutat Res 2003; 522: 69-83.
11. Saintigny Y, Rouillard D, Chaput B, et al. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 1999; 18: 3553-63.
12. Lambert S, Lopez BS. Characterization of mammalian RAD51 double strand break repair using non lethal dominant negative forms. EMBO J 2000; 19: 3090-9.
13. Wang YY, Maher VM, Liskay RM, McCormick JJ. Carcinogens can induce homologous recombination between duplicated chromosomal sequences in mouse L cells. Mol Cell Biol 1988; 8: 196-202.
14. Akyuz N, Boehden GS, Susse S, et al. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol Cell Biol 2002; 22: 6306-17.
15. Michel B, Flores MJ, Viguera E, et al. Rescue of arrested replication forks by homologous recombination. Proc Natl Acad Sci USA 2001; 98: 8181-8.
16. Saintigny Y, Delacote F, Vares G, et al. Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J 2001; 20: 3861-70.
17. Saintigny Y, Lopez BS. Homologous recombination induced by replication inhibition is stimulated by expression of mutant p53. Oncogene 2002; 21: 488-92.
18. Janz C, Wiesmuller L. Wild-type p53 inhibits replication-associated homologous recombination. Oncogene 2002; 21: 5929-33.
19. Sengupta S, Linke SP, Pedeux R, et al. BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J 2003; 22: 1210-22.
20. Dudenhoffer C, Kurth M, Janus F, et al. Dissociation of the recombination control and the sequence-specific transactivation function of p53. Oncogene 1999; 18: 5773-84.
21. Willers H, McCarthy EE, Wu B, et al. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 2000; 19: 632-9.
22. Linke SP, Sengupta S, Khabie N, et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 2003; 63: 2596-605.
23. Yoon D, Wang Y, Stapleford K, et al. P53 inhibits strand exchange and replication fork regression promoted by human Rad51. J Mol Biol 2004; 336: 639-54.
24. Lee S, Cavallo L, Griffith J. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J Biol Chem 1997; 272: 7532-9.
25. Lee S, Elenbaas B, Levine A, Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 1995; 81: 1013-20.
26. Buchhop S, Gibson MK, Wang XW, et al. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res 1997; 25: 3868-74.
27. Bertrand P, Saintigny Y, Lopez BS. p53's double life: transactivation-independent repression of homologous recombination. Trends Genet 2004; 20: 235-43.
28. Dudenhoffer C, Rohaly G, Will K, et al. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol 1998; 18: 5332-42.
29. Susse S, Janz C, Janus F, et al. Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene 2000; 19: 4500-12.
30. Degtyareva N, Subramanian D, Griffith JD. Analysis of the binding of p53 to DNAs containing mismatched and bulged bases. J Biol Chem 2001; 276: 8778-84.
31. Zink D, Mayr C, Janz C, Wiesmuller L. Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene 2002; 21: 4788-800.
32. Subramanian D, Griffith JD. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res 2002; 30: 2427-34.
33. Waldman AS, Liskay RM. Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology. Mol Cell Biol 1988; 8: 5350-7
34. Rayssiguier C, Thaler DS, Radman M. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 1989; 342: 396-401.
35. Jimenez GS, Nister M, Stommel JM, et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat Genet 2000; 26: 37-43.
36. Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285: 1733-7.
37. Deng C, Zhang P, Harper JW, et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82: 675-84.
38. Szostak JW, Orr-Weaver TL, Rothstein RJ, Stahl FW. The double-strand-break repair model for recombination. Cell 1983; 33: 25-35.
39. Rossignol JL. La recombinaison homologue: mécanismes et conséquences. Med Sci (Paris) 1990; 6: 4-9.